Newswise — Beth Israel Deaconess Medical Center (BIDMC) in Boston has two pancreatic cancer experts available for interview.
Pancreatic cancer accounts for about three percent of all cancers in the United States and about seven percent of all cancer deaths. According to the American Cancer Society, an estimated 56,770 people (29,940 men and 26,830 women) will be diagnosed with pancreatic cancer in the United States this year.
The Cancer Center at BIDMC has two experts available for general inquiries surrounding pancreatic cancer:
- Arthur J. Moser, MD, Co-Director of BIDMC’s Pancreas and Liver Institute, is a leader in complex, advanced surgical oncology including minimally-invasive surgery of the pancreas and liver and vascular resection for borderline resectable tumors. Dr. Moser’s current areas of primary interest include: minimally-invasive cancer surgery; biomarker development and computational biology approaches to precision medicine for pancreatic diseases, and particularly pancreatic cancer.
- Andrea J. Bullock, MD, MPH, is a hematology oncologist and a founding member of the Pancreatic Cancer Center at BIDMC. Her research efforts focus on improving understanding of cancer pathogenesis and developing rationally resigned therapeutic strategies to address the needs of patients with pancreatic cancer.
Please reach out to Teresa Herbert at email@example.com if you are interested in setting up an interview.